Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis
- PMID: 28779882
- DOI: 10.1016/S2214-109X(17)30293-0
Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis
Abstract
Background: Global and regional prevalence estimates for blindness and vision impairment are important for the development of public health policies. We aimed to provide global estimates, trends, and projections of global blindness and vision impairment.
Methods: We did a systematic review and meta-analysis of population-based datasets relevant to global vision impairment and blindness that were published between 1980 and 2015. We fitted hierarchical models to estimate the prevalence (by age, country, and sex), in 2015, of mild visual impairment (presenting visual acuity worse than 6/12 to 6/18 inclusive), moderate to severe visual impairment (presenting visual acuity worse than 6/18 to 3/60 inclusive), blindness (presenting visual acuity worse than 3/60), and functional presbyopia (defined as presenting near vision worse than N6 or N8 at 40 cm when best-corrected distance visual acuity was better than 6/12).
Findings: Globally, of the 7·33 billion people alive in 2015, an estimated 36·0 million (80% uncertainty interval [UI] 12·9-65·4) were blind (crude prevalence 0·48%; 80% UI 0·17-0·87; 56% female), 216·6 million (80% UI 98·5-359·1) people had moderate to severe visual impairment (2·95%, 80% UI 1·34-4·89; 55% female), and 188·5 million (80% UI 64·5-350·2) had mild visual impairment (2·57%, 80% UI 0·88-4·77; 54% female). Functional presbyopia affected an estimated 1094·7 million (80% UI 581·1-1686·5) people aged 35 years and older, with 666·7 million (80% UI 364·9-997·6) being aged 50 years or older. The estimated number of blind people increased by 17·6%, from 30·6 million (80% UI 9·9-57·3) in 1990 to 36·0 million (80% UI 12·9-65·4) in 2015. This change was attributable to three factors, namely an increase because of population growth (38·4%), population ageing after accounting for population growth (34·6%), and reduction in age-specific prevalence (-36·7%). The number of people with moderate and severe visual impairment also increased, from 159·9 million (80% UI 68·3-270·0) in 1990 to 216·6 million (80% UI 98·5-359·1) in 2015.
Interpretation: There is an ongoing reduction in the age-standardised prevalence of blindness and visual impairment, yet the growth and ageing of the world's population is causing a substantial increase in number of people affected. These observations, plus a very large contribution from uncorrected presbyopia, highlight the need to scale up vision impairment alleviation efforts at all levels.
Funding: Brien Holden Vision Institute.
Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Comment in
-
Universal eye health: are we getting closer?Lancet Glob Health. 2017 Sep;5(9):e843-e844. doi: 10.1016/S2214-109X(17)30302-9. Epub 2017 Aug 2. Lancet Glob Health. 2017. PMID: 28779883 No abstract available.
Similar articles
-
Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis.Lancet Glob Health. 2017 Dec;5(12):e1221-e1234. doi: 10.1016/S2214-109X(17)30393-5. Epub 2017 Oct 11. Lancet Glob Health. 2017. PMID: 29032195
-
Global burden of vision impairment due to age-related macular degeneration, 1990-2021, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021.Lancet Glob Health. 2025 Jul;13(7):e1175-e1190. doi: 10.1016/S2214-109X(25)00143-3. Lancet Glob Health. 2025. PMID: 40580986 Free PMC article.
-
Global prevalence of vision impairment and blindness: magnitude and temporal trends, 1990-2010.Ophthalmology. 2013 Dec;120(12):2377-2384. doi: 10.1016/j.ophtha.2013.05.025. Epub 2013 Jul 10. Ophthalmology. 2013. PMID: 23850093
-
Visual impairment and blindness due to macular diseases globally: a systematic review and meta-analysis.Am J Ophthalmol. 2014 Oct;158(4):808-15. doi: 10.1016/j.ajo.2014.06.012. Epub 2014 Jun 25. Am J Ophthalmol. 2014. PMID: 24973605
-
Community screening for visual impairment in older people.Cochrane Database Syst Rev. 2018 Feb 20;2(2):CD001054. doi: 10.1002/14651858.CD001054.pub3. Cochrane Database Syst Rev. 2018. PMID: 29460275 Free PMC article.
Cited by
-
Inhibition of viability of human retinal microvascular endothelial cells by vialinin A under high glucose condition.Int J Ophthalmol. 2024 Oct 18;17(10):1809-1815. doi: 10.18240/ijo.2024.10.06. eCollection 2024. Int J Ophthalmol. 2024. PMID: 39430017 Free PMC article.
-
EyeDiseases: an integrated resource for dedicating to genetic variants, gene expression and epigenetic factors of human eye diseases.NAR Genom Bioinform. 2021 Jun 1;3(2):lqab050. doi: 10.1093/nargab/lqab050. eCollection 2021 Jun. NAR Genom Bioinform. 2021. PMID: 34085038 Free PMC article.
-
Markedly decreasing incidence of cause-specific blindness in Saxony (Eastern Germany).Graefes Arch Clin Exp Ophthalmol. 2021 May;259(5):1089-1101. doi: 10.1007/s00417-020-04885-4. Epub 2020 Sep 25. Graefes Arch Clin Exp Ophthalmol. 2021. PMID: 32974733 Review.
-
Cataract surgery in surgical camps: outcomes in a rural area of Cameroon.Int Ophthalmol. 2021 Jan;41(1):283-292. doi: 10.1007/s10792-020-01580-5. Epub 2020 Sep 26. Int Ophthalmol. 2021. PMID: 32979111
-
Improvement in Accommodation and Dynamic Range of Focus After Laser Scleral Microporation: A Potential Treatment for Presbyopia.Transl Vis Sci Technol. 2022 Dec 1;11(12):2. doi: 10.1167/tvst.11.12.2. Transl Vis Sci Technol. 2022. PMID: 36454577 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical